2 completed, 1 recruiting, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Cervical Dysplasia: new trials by email Literature Review of Cervical Dysplasia trials Research Report on Cervical Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) Artesunate vaginal insert, Placebo vaginal insert - CIN 2/3, HPV Infection | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 78 | 2020-09-09 | 2025-10-02 |
| A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia Nelfinavir - Cervical Dysplasia | Phase 2 | Withdrawn | The University of Texas Health Science Center, Houston | 2018-11-07 | 2020-11-12 | |
| Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) 9-valent HPV vaccine, Imiquimod - Cervical Intraepithelial Neoplasia, Cervical Dysplasia | Phase 2 | Completed | Yale University | 134 | 2016-07-01 | 2024-05-02 |
| A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) - Cervical Dysplasia | Phase 1 / Phase 2 | Completed | Photocure | 96 | 2006-08-01 | 2010-11-30 |
Uterine Cervical Dysplasia (4) · Papillomavirus Infections (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Neoplasms (4) · Precancerous Conditions (4) · Urogenital Diseases (4) · Uterine Cervical Diseases (4) · Uterine Diseases (4) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
5-aminolevulinic acid hexyl ester (1) · Imiquimod (1) · Nelfinavir (1) · artemisinin (1) · artesunic acid (1) · methyl 5-aminolevulinate (1)
Frantz Viral Therapeutics, LLC (1) · Photocure (1) · The University of Texas Health Science Center, Houston (1) · Yale University (1)
United States (3) · Germany (1) · Norway (1)
Alessandro D Santin, MD (1) · Joseph A Lucci, MD (1) · Peter Hillemanns, Md PhD (1) · Sangini S Sheth, MD, MPH (1)